Cargando…
An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric Cancer
SIMPLE SUMMARY: Helicobacter pylori (HP) infection is the greatest risk factor for gastric cancer (GC), and over half of the world’s population is colonized with HP. Up to now, many gene signatures are designed for predicting the prognosis of GC patients, while there are no signatures designed speci...
Autores principales: | Geng, Haigang, Dong, Zhongyi, Zhang, Linmeng, Yang, Chen, Li, Tingting, Lin, Yuxuan, Ke, Shouyu, Xia, Xiang, Zhang, Zizhen, Zhao, Gang, Zhu, Chunchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265823/ https://www.ncbi.nlm.nih.gov/pubmed/35805047 http://dx.doi.org/10.3390/cancers14133276 |
Ejemplares similares
-
Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer
por: Geng, Haigang, et al.
Publicado: (2022) -
Development and validation of two nomograms for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: A retrospective cohort study from SEER database
por: Dong, Zhongyi, et al.
Publicado: (2022) -
High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
por: Ke, Shouyu, et al.
Publicado: (2022) -
Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia
por: Song, Lusheng, et al.
Publicado: (2022) -
Helicobacter pylori and Gastric Cancer
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)